Postoperative Pain Relief After Major Abdominal Gynecological Surgery
NCT ID: NCT05845385
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2024-05-06
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COMPARISON OF PLAIN BLOCKS FOR POSTOPERATIVE PAIN MANAGEMENT IN GYNECOLOGICAL ABDOMINAL SURGERIES
NCT07021105
Quadratus Lumborum Block vs Erector Spinae Plane Block in Laparoscopic Hysterectomy
NCT05465525
Transversus Abdominis Plane Block for Postoperative Pain Management in Gynaecological Cancer Surgery
NCT07077863
The Effect of Analgesia Methods Applied in Gynecological Cancer Surgeries on Postoperative Analgesia
NCT06382376
Comparison of the Effects of TFPB and Anterior QLB on Postoperative Analgesia in Cesarean Section Surgery
NCT05408403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lumbar epidural analgesia with bupivacaine
For postoperative analgesia; Lumbar epidural catheter inserted at L3-4 or L4-5 epidural space before anesthesia induction in the sitting position. After the end of surgery but approximately 20 minutes before extubation, 0.125% bupivacaine 20 ml administered through epidural catheter and the catheter was removed.
lumbar epidural analgesia with bupivacaine
postoperative analgesic method
transversus abdominis plane block with bupivacaine
For postoperative analgesia; After the end of surgery but before extubation, USD-guided TAP block was performed with 0.125% bupivacaine 20 ml to the anatomic neurofacial space between the internal oblique and transersus abdominis muscles, bilaterally (10 ml for each side).
transversus abdominis plane block with bupivacaine
postoperative analgesic method
wound infiltration with bupivacaine
For postoperative analgesia; After the end of surgery but before extubation, 0.125% bupivacaine 20 ml administered to the surgical incision site.
wound infiltration with bupivacaine
postoperative analgesic method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lumbar epidural analgesia with bupivacaine
postoperative analgesic method
transversus abdominis plane block with bupivacaine
postoperative analgesic method
wound infiltration with bupivacaine
postoperative analgesic method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between the age of 18-69,
* undergoing major gynecological abdominal surgery under general anesthesia
Exclusion Criteria
* ASA \> III
* sensitivity or contraindication to study drugs
* conditions in which epidural anesthesia is contraindicated
* emergency and urgent surgery
* inability to comprehend pain scale
* any contraindication to the use of patient controlled analgesia (PCA) device.
18 Years
69 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cukurova University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hakki Unlugenc
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hakkı - Unlugenc, Proffessor
Role: STUDY_CHAIR
Cukurova University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cukurova University
Adana, , Turkey (Türkiye)
Cukurova University
Adana, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.